PubMed:23952588 / 1278-1401 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T17","span":{"begin":0,"end":123},"obj":"Sentence"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}

{"project":"LitCoin-entities","denotations":[{"id":"9348","span":{"begin":36,"end":46},"obj":"DiseaseOrPhenotypicFeature"},{"id":"9349","span":{"begin":64,"end":72},"obj":"ChemicalEntity"},{"id":"9350","span":{"begin":109,"end":117},"obj":"ChemicalEntity"}],"attributes":[{"id":"A26","pred":"db_id","subj":"9348","obj":"MESH:D004409"},{"id":"A27","pred":"db_id","subj":"9349","obj":"MESH:D007980"},{"id":"A28","pred":"db_id","subj":"9350","obj":"MESH:D007980"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T14","span":{"begin":97,"end":102},"obj":"GeneOrGeneProduct"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T16","span":{"begin":36,"end":46},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A16","pred":"originalLabel","subj":"T16","obj":"D020820"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T16","span":{"begin":36,"end":46},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A16","pred":"ID:","subj":"T16","obj":"D020820"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T14","span":{"begin":36,"end":46},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A14","pred":"#label","subj":"T14","obj":"D020820"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T8","span":{"begin":64,"end":72},"obj":"ChemicalEntity"},{"id":"T9","span":{"begin":109,"end":117},"obj":"ChemicalEntity"}],"attributes":[{"id":"A8","pred":"ID:","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"},{"id":"A9","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T9","span":{"begin":109,"end":117},"obj":"ChemicalEntity"},{"id":"T8","span":{"begin":64,"end":72},"obj":"ChemicalEntity"},{"id":"T14","span":{"begin":36,"end":46},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A9","pred":"ID:","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"},{"id":"A8","pred":"ID:","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"},{"id":"A14","pred":"#label","subj":"T14","obj":"D020820"}],"text":"The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose."}